Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India flag India · Delayed Price · Currency is INR
22.94
-1.06 (-4.42%)
At close: Jun 1, 2026

BOM:531015 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
2.48-0.110.652.2618.46
Depreciation & Amortization
0.040.060.070.080.09
Loss (Gain) From Sale of Assets
-0.19---
Other Operating Activities
-0-0.04-0.0100
Change in Accounts Receivable
-4.78-9.530.36--0
Change in Inventory
-9.41-0.58---
Change in Accounts Payable
10.495.25-2.25-1.420.06
Change in Other Net Operating Assets
-108.78-18.171.2-0.950.44
Operating Cash Flow
-109.96-22.90.02-0.0319.05
Operating Cash Flow Growth
----621.97%
Short-Term Debt Issued
---0.03-
Long-Term Debt Issued
2.81----
Total Debt Issued
2.81--0.03-
Short-Term Debt Repaid
-----19.8
Long-Term Debt Repaid
--3.03---
Total Debt Repaid
--3.03---19.8
Net Debt Issued (Repaid)
2.81-3.03-0.03-19.8
Other Financing Activities
94.5650.73---
Financing Cash Flow
97.3747.7-0.03-19.8
Miscellaneous Cash Flow Adjustments
-----0
Net Cash Flow
-12.5924.80.02--0.75
Free Cash Flow
-109.96-22.90.02-0.0319.05
Free Cash Flow Growth
----621.97%
Free Cash Flow Margin
-137.03%-283.69%---
Free Cash Flow Per Share
-9.30-4.370.00-0.013.64
Cash Income Tax Paid
0.29-0.23--
Levered Free Cash Flow
-111.72-29.5-1.32-3.5-0.27
Unlevered Free Cash Flow
-111.72-29.5-1.32-3.5-0.27
Change in Working Capital
-112.48-23.01-0.69-2.370.5